Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists

Details for Australian Patent Application No. 2005316676 (hide)

Owner Merck & Co., Inc.

Inventors Young, Jonathan R.; Mills, Sander G.; Jiang, Jinlong; Devita, Robert J.

Agent Spruson & Ferguson

Pub. Number AU-A-2005316676

PCT Pub. Number WO2006/065711

Priority 60/638,065 20.12.04 US; 60/635,777 14.12.04 US

Filing date 12 December 2005

Wipo publication date 22 June 2006

International Classifications

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

C07D 491/02 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/065711 Priority application(s): WO2006/065711

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316682-Underwater visibility device

2005316675-Use of a 5-HT6 agonist for the treatment and prevention of neurodegenerative disorders